搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
FierceBiotech
15 小时
In 2 papers, researchers describe potential new neurodegenerative disease treatment approach
William McEwan, Ph.D., spent years unraveling how an antiviral protein, tripartite motif-containing 21 (TRIM21), protects our ...
FierceBiotech
16 小时
Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability ...
Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...
FierceBiotech
13 小时
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...
FierceBiotech
16 小时
Aligos' MASH prospect slashes liver fat in phase 2, but stock drops anyway
Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction associated steatohepatitis (MASH) after three ...
FierceBiotech
17 小时
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 ...
FierceBiotech
23 小时
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell ...
GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...
FierceBiotech
21 小时
Inflammation-focused Upstream set to join growing trickle of biotech IPOs
The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...
FierceBiotech
1 天
NIH grants up to $100M yearly for pandemic preparedness network
With COVID-19 still spreading and mpox emerging as a public health emergency of international concern, the National ...
FierceBiotech
1 天
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond ...
Novo Nordisk is continuing its push into genetic medicines, agreeing to pay NanoVation Therapeutics up to $600 million to ...
FierceBiotech
1 天
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s ...
Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...
FierceBiotech
1 天
Capricor sells Europe rights to DMD therapy for $35M as FDA application approaches
Having already scooped up the U.S. rights to Capricor Therapeutics’ late-stage Duchenne muscular dystrophy (DMD) therapy, ...
FierceBiotech
2 天
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data
A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈